CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
OPERATING ACTIVITIES
Net loss	$ (380)	$ (1,755)
Non cash items:
Amortization	157	205
Non-cash interest expense	238	68
Non-cash stock-based interest expense	15	0
Change in other operating items:
Other current assets	1	26
Accounts payable	48	(52)
Other accrued liabilities	(13)	(53)
Cash flows provided by (used in) operating activities	66	(1,561)
INVESTING ACTIVITIES
Cash flows provided by investing activities	0	0
FINANCING ACTIVITIES
Sale of Commmon Stock	0	1,013
LipimetiX Development, Inc. Series B-2 Preferred Stock transaction costs	0	(15)
Pay-off of Convertible Promissory Notes	0	(1,000)
Issuance of Secured Debt, net of issuance costs of $287	0	2,140
Cash flows provided by financing activities	0	2,138
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	66	577
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	1,275	698
CASH AND CASH EQUIVALENTS, END OF PERIOD	$ 1,341	$ 1,275